CAS 26166-39-2

26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)benzaldehyde (1R-(1alpha(2E,4E),2beta,6beta))- Ilicicolin D LL-Z 1272 gamma NSC 287492 UNII-PEZ8F05ODV

纯度 97%+现货药物标准品
CAS 号26166-39-2
分子式C23H29ClO4
分子量404.93 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)benzaldehyde (1R-(1alpha(2E,4E),2beta,6beta))- Ilicicolin D LL-Z 1272 gamma NSC 287492 UNII-PEZ8F05ODV CAS 26166-39-2 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)benzaldehyde (1R-(1alpha(2E,4E),2beta,6beta))- Ilicicolin D LL-Z 1272 gamma NSC 287492 UNII-PEZ8F05ODV）为药物标准品，CAS 登记号 26166-39-2，分子式 C23H29ClO4，分子量 404.93。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

在质量保证方面，的生产和定值严格遵循ISO 17034:2016（认证标准物质生产者）的要求。纯度定值采用质量平衡法和定量核磁共振（qNMR）等多种正交方法进行交叉验证，扩展不确定度报告为95%置信水平（k=2）。每个批次的均匀性和稳定性均经过独立的统计评估。 CAS编号 26166-39-2 对应的化合物（英文标识 26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chl

应用场景：针对化学分析用途，（26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (

理化性质 Physical & Chemical Properties

中文名称
分子式C23H29ClO4
分子量404.93 g/mol
外观形态淡黄色至黄色结晶性粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）9.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1964年
卤素含量Cl取代

相关专利 Related Patents

  1. 发明人李文辉，朱建伟，冯建国. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 110182010 B, 授权公告日 2019-06-27.
  2. O'Brien P Q, Klinger H, Yamamoto T. "Method for the Synthesis of 26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)benzaldehyde (1R-(1alpha(2E,4E),2beta,6beta))- Ilicicolin D LL-Z 1272 gamma NSC 287492 UNII-PEZ8F05ODV" [P]. US Patent, US 10466205 B2, 2022-06-28.

参考文献 Literature

  1. Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2012, 1992, 5163-5171.
  2. Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2019, 1723, (6), 3412-3417.
  3. Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 26166-39-2 PEZ8F05ODV Ascochlorin Benzaldehyde, 3-chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (1R-(1alpha(2E,4E),2beta,6beta))- beta-Resorcylaldehyde, 5-chloro-6-methyl-3-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)-, (E,E)- Antibiotic LL-Z1272 gamma 3-Chloro-4,6-dihydroxy-2-methyl-5-(3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)-2,4-pentadienyl)benzaldehyde (1R-(1alpha(2E,4E),2beta,6beta))- Ilicicolin D LL-Z 1272 gamma NSC 287492 UNII-PEZ8F05ODV Using HRMS and NMR". J. Sep. Sci., 2024, 896, (1), 4926-4933.
  4. Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2016, 977, (6), 6644-6672.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...